Active packaging growth Aptar CSP Technologies specializes in active material science packaging solutions that extend shelf life and improve product stability, presenting opportunities to upsell packaging innovations for pharmaceutical, food safety, and consumer care clients seeking differentiation and better shelf integrity.

Cold chain readiness With expertise spanning concept through global production and regulatory support, there is a strong cross-sell opportunity to pharma customers requiring end-to-end packaging solutions that preserve drug integrity during storage and distribution, including injectable and oral solid dose formats.

New capacity expansion Recent facility expansion in New Jersey and ongoing manufacturing capabilities position Aptar CSP Technologies to handle increased clinical-stage packaging demand, enabling sales teams to target growing biotech and pharmaceutical companies advancing into late-stage trials.

Innovation awards Recognition such as the 2025 Pharma Innovation Award for Dual-Guard Active Material Science Technology signals differentiated offerings that can be leveraged to engage potential customers seeking validated, award-winning solutions for drug stability, containment, and patient experience.

Integrated solutions The end-to-end service model from ideation to regulatory support matches customers seeking risk-reduced development timelines, creating cross-sell opportunities into adjacent Aptar groups for comprehensive drug delivery systems, elastomeric components, and activating materials.